The SGLT2 inhibitor ertugliflozin causes a switch of cardiac substrate utilization leading to reduced cardiac mTOR-signaling, unfolded protein response and apoptosis.
27 August 2021 (00:00 - 00:00)
Organised by:
About the speaker
RWTH University Hospital Aachen, Aachen (Germany)
19 More presentations in this session
Doctor S. Margraf (Essen, DE)
The m6A methyltransferase METTL3 promotes hypoxic pulmonary arterial hypertension via targeting PTEN
Doctor Y. Qin (Nanjing, CN)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
27 August - 30 August 2021
You may be interested in
Congress Presentation
Congress Presentation
